DS

Dilipkumar Satilal Chokshi

Active Director Director DIN 00877387
DIN 00877387 First appointment Nov 2006 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2006
Shareholding value β€’β€’β€’β€’ Premium profile

About Dilipkumar Satilal Chokshi

Data last updated:

Dilipkumar Satilal Chokshi is a Director at Medilink Finechem Private Limited (since 2006). The company operates in Pharma.

DIN 00877387
Primary Designation Director
Industry Pharma
First Appointment 30 Nov 2006
Oldest Company Age 19 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medilink Finechem Private Limited U24233GJ2006PTC049498
Director30 Nov 20062006Active

Board colleagues of Dilipkumar Satilal Chokshi

Directorship timeline

Open interactive timeline →
Medilink Finechem Private Limited
Premium access

Shareholding and investment profile for Dilipkumar Satilal Chokshi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dilipkumar Satilal Chokshi

Dilipkumar Satilal Chokshi currently holds 1 directorship: Medilink Finechem Private Limited (Director, since 30 Nov 2006).

Dilipkumar Satilal Chokshi was first appointed on 30 Nov 2006 as Director at Medilink Finechem Private Limited.

The current boards of Dilipkumar Satilal Chokshi's companies include Jetra Dilipkumar Chokshi (Medilink Finechem Private Limited), Manoj Kanaiyalal Shah (Medilink Finechem Private Limited), Nila Manojkumar Shah (Medilink Finechem Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available